Sembaruthi Pharmacies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 20-12-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.91 Cr
as on 20-12-2024
- Revenue -8.26%
(FY 2021)
- Profit -8.53%
(FY 2021)
- Ebitda 8.29%
(FY 2021)
- Net Worth 10.13%
(FY 2021)
- Total Assets -20.17%
(FY 2021)
About Sembaruthi Pharmacies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.91 Cr.
Sriramulu Radhika and Ganesh Devi serve as directors at the Company.
- CIN/LLPIN
U51909TN2014PTC097799
- Company No.
097799
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sembaruthi Pharmacies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Devi  | Managing Director | 23-Oct-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sriramulu Radhika | Director | 23-Oct-2014 | Current |
Financial Performance of Sembaruthi Pharmacies.
Sembaruthi Pharmacies Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 8.26% decrease. The company also saw a slight decrease in profitability, with a 8.53% decrease in profit. The company's net worth Soared by an impressive increase of 10.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sembaruthi Pharmacies?
In 2021, Sembaruthi Pharmacies had a promoter holding of 59.00% and a public holding of 41.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jul 2024 | ₹1.65 M | Open |
Axis Bank Limited Creation Date: 15 Sep 2022 | ₹1.40 Cr | Open |
Others Creation Date: 09 Feb 2018 | ₹3.50 M | Open |
How Many Employees Work at Sembaruthi Pharmacies?
Sembaruthi Pharmacies has a workforce of 40 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sembaruthi Pharmacies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sembaruthi Pharmacies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
